This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2021
  • /
  • 9
  • /
  • Cassiopea SpA and Sun Pharma announce that Sun Pha...
News

Cassiopea SpA and Sun Pharma announce that Sun Pharma will commercialise Winlevi, a treatment for acne, in the US and Canada.

Read time: 1 mins
Published:1st Sep 2021
Cassiopea SpA and Sun Pharmaceutical Industries Ltd have .announced the expiration of the applicable waiting period under the US Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) in connection with the exclusive License and Supply Agreements signed by both companies for Winlevi (clascoterone cream 1%), The agreements are effective as of August 31, 2021.

Sun Pharma now has the exclusive right to commercialize Winlevi in the United States and Canada. Cassiopea will be the exclusive supplier of the product. Winlevi is expected to be available in the U.S. in Q4 2021.

Condition: Acne
Type: drug

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Related news and insights